Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
General Counsel
-
Stock Symbol
-
URGN on Nasdaq
Jason D. Smith - trading volume in the past year for UroGen Pharma Ltd.
Holdings reported by Jason D. Smith for UroGen Pharma Ltd.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Ordinary Shares |
25.2K |
$330K |
$13.08 |
Sep 9, 2024 |
Direct |
|
|
Restricted Stock Units |
6.67K |
|
|
Sep 9, 2024 |
Direct |
Ordinary Shares |
|
Transactions reported by Jason D. Smith for UroGen Pharma Ltd.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.